Child Categories
Food & Drug Law
-
Developing an Ethics and Policy Framework for Psychedelic Clinical Care: A Consensus Statement
March 20, 2026
Amy L. McGuire, I. Glenn Cohen, Dominic Sisti et al., Developing an Ethics and Policy Framework for Psychedelic Clinical Care: A Consensus Statement, 7 JAMA…
-
How Should the FDA Evaluate Psychedelic Medicine?
March 20, 2026
Mason Marks & I. Glenn Cohen, How Should the FDA Evaluate Psychedelic Medicine?, 389 New England J. Med. 1733 (2023).
-
Microdosing Psychedelics Under Local, State, and Federal Law
March 20, 2026
Mason Marks, I. Glenn Cohen, Jonathan Perez- Reyzin et al., Microdosing Psychedelics Under Local, State, and Federal Law, 103 B.U. L. Rev. 101 (2023).
-
Mason Marks & I. Glenn Cohen, Psychedelic Therapy: A Roadmap for Wider Acceptance and Utilization, 27 Nat. Med. 1669 (2021).
-
Regulatory, Safety, and Privacy Concerns of Home Monitoring Technologies During COVID-19
March 20, 2026
Sara Gerke, Carmel Shachar, Peter R. Chai & I. Glenn Cohen, Regulatory, Safety, and Privacy Concerns of Home Monitoring Technologies During COVID-19, 26 Nature Med.
-
Ten Years Post-GAO Assessment, FDA Remains Uninformed of Potentially Harmful GRAS Substances in Foods
March 20, 2026
Cameron Faustman, Daniel Aaron, Nicole Negowetti & Emily Broad Leib, Ten Years Post-GAO Assessment, FDA Remains Uninformed of Potentially Harmful GRAS Substances in Foods, 61…
-
Misunderstood Food Date Labels and Reported Food Discards: A Survey of U.S. Consumer Attitudes and Behaviors
March 20, 2026
Roni A. Neff, Marie Spiker, Christina Rice, Alexandra Schklair, Sally Greenberg & Emily Broad Leib, Misunderstood Food Date Labels and Reported Food Discards: A Survey…
-
When Clinical Trials Compete: Prioritising Study Recruitment
March 17, 2026
Luke Gelinas, Holly Fernandez Lynch, Barbara E. Bierer & I. Glenn Cohen, When Clinical Trials Compete: Prioritising Study Recruitment, 43 J. Med. Ethics 803 (2017).
-
Jennifer L. Pomeranz, Sean B. Cash, Emily Broad Leib et al., Advancing The FDA’s Human Foods Program Through Additional Authorities And User Fees, 44 Health…
-
The Evolution and Scope of Medicaid Section 1115 Demonstrations to Address Nutrition: A U.S. Survey
March 15, 2026
Erika Hanson, Daniel Albert-Rozenberg, Kathryn M. Garfield et al., The Evolution and Scope of Medicaid Section 1115 Demonstrations to Address Nutrition: A U.S. Survey, 2…
-
States’ Use Of Medicaid Managed Care ‘In Lieu Of Services’ Authority To Address Poor Nutrition
March 12, 2026
Kathryn Garfield, Erika Hanson, Carmel Shachar et al., States’ Use Of Medicaid Managed Care ‘In Lieu Of Services’ Authority To Address Poor Nutrition, 44 Health…
-
Essentials of Informed Consent to Psychedelic Medicine
March 12, 2026
Mason Marks, Rebecca W. Brendel, Carmel Shachar et al., Essentials of Informed Consent to Psychedelic Medicine, 81 JAMA Psychiatry 611 (2024).
-
Proposed Nutrition Competencies for Medical Students and Physician Trainees: A Consensus Statement
March 12, 2026
David M. Eisenberg, Alexis Cole, Edward J. Maile et al., Proposed Nutrition Competencies for Medical Students and Physician Trainees: A Consensus Statement, 7 JAMA Network…
-
The Time is Ripe: The Case for Nutrition in Graduate Medical Education in the United States
March 12, 2026
Bethany Agusala, Emily Broad Leib & Jaclyn Albin, The Time is Ripe: The Case for Nutrition in Graduate Medical Education in the United States, 11…
-
Katharine Van Tassel, Carmel Shachar & Sharona Hoffman, Covid-19 Vaccine Injuries — Preventing Inequities in Compensation, New England J. Med. (2021).
-
Lessons from COVID-19 for behavioural and communication interventions to enhance vaccine uptake
March 6, 2026
Stephan Lewandowsky, Philipp Schmid, Katrine Bach Habersaat et al., Lessons from COVID-19 for behavioural and communication interventions to enhance vaccine uptake, 1 Commc’ns Psych. (2023).
-
Eli Y. Adashi, Daniel P. O’Mahony & I. Glenn Cohen, The FDA Modernization Act 2.0: Drug Testing in Animals is Rendered Optional, Am. J. Med.
-
John H. Rex, Holly Fernandez Lynch, I. Glenn Cohen, Jonathan J. Darrow & Kevin Outterson, Designing Development Programs for Non-Traditional Antibacterial Agents, 10 Nature Comm.